Editorial
Published on 13 Sep 2022
Editorial: Diagnostic and predictive biomarkers in testicular germ cell tumors
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1027363
- 1,225 views
- 4 citations
Type at least 3 characters
1,560 articles
Articles
Original Research
Published on 13 Sep 2022
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.973402
- 3,058 views
- 4 citations
Original Research
Published on 13 Sep 2022
Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.948113
- 1,740 views
Original Research
Published on 13 Sep 2022
Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.976407
- 4,665 views
- 11 citations
Original Research
Published on 13 Sep 2022
The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.961086
- 7,690 views
- 8 citations
Original Research
Published on 12 Sep 2022
Fibroblasts mediate the angiogenesis of pheochromocytoma by increasing COX4I2 expression
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.938123
- 2,434 views
- 8 citations
Original Research
Published on 12 Sep 2022
A positive feedback loop between tryptophan hydroxylase 1 and β-Catenin/ZBP-89 signaling promotes prostate cancer progression
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.923307
- 2,232 views
- 4 citations
Editorial
Published on 08 Sep 2022
Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1021870
- 2,278 views
- 2 citations
Original Research
Published on 07 Sep 2022
Detecting and monitoring bladder cancer with exfoliated cells in urine
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.986692
- 3,013 views
- 1 citation
Original Research
Published on 06 Sep 2022
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.968384
- 1,593 views
- 4 citations
Original Research
Published on 05 Sep 2022
Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A single-center experience
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.980564
- 1,613 views
- 4 citations
Mini Review
Published on 05 Sep 2022
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.962897
- 2,636 views
- 1 citation
Systematic Review
Published on 05 Sep 2022
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955894
- 2,533 views
- 3 citations
Systematic Review
Published on 02 Sep 2022
Diagnostic performance of radiomics in adrenal masses: A systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975183
- 3,114 views
- 6 citations
Original Research
Published on 01 Sep 2022
Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.976329
- 3,108 views
- 16 citations
Original Research
Published on 31 Aug 2022
Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.957404
- 3,562 views
- 8 citations